Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Great Article CS!
View:
Post by livermore2 on Jul 11, 2021 11:50am

Great Article CS!

This surely is game changing cancer curing technology. Nice to see the word spreading south of the border! Would be great to get this listed on the NASDAQ.
Comment by Mikee3003 on Jul 11, 2021 3:06pm
Listing on the NASDAQ would be so nice! Remembering how not that long ago PYR went ballistic when they annouced the same. Good things to come in 2022! GLTA Mikee
Comment by Oilminerdeluxe on Jul 11, 2021 3:37pm
Nasdaq would be sweet indeed. Just a minor obstacle left, a tiny, minute little thing to overcome. We are at 24 cents... But with a little luck, the Nasdaq party might arrive one day :-)
Comment by livermore2 on Jul 11, 2021 5:04pm
24 cents is an opportunity not an obstacle. I will be adding this week. Good luck all!
Comment by Longholder99 on Jul 11, 2021 5:33pm
I assume Big Pharm is completely aware of this tech and is simply choosing not to address or recognize it until they have no choice. They will continue to sell franken immuno manipulators as long as they can. When they do decide to take control of this tech (they will) it will be good for all of us. There will be no warning. All IMO.
Comment by StevenBirch on Jul 12, 2021 8:23am
I agree completely and think that anyone interested in this company has been accumulating and will continue to do so. Also if/when good results come in they will be the ones to cause it to gap up and not retail schmucks like us although that would add to the buying frenzy. If they had a good base position down here, endless amounts of cash and good results they would probably buy all they can ...more  
Comment by gonefishing2022 on Jul 12, 2021 2:36pm
I AGREE WE JUST NEED THE RESULTS..If good results this will fly. THOSE RESULTS COULD BE LATER TODAY OR IN 2 MONTHS
Comment by Kingpin68 on Jul 12, 2021 4:53pm
< i agree we just need the results..if good results this will fly. those results could be later today or in 2 months from the previous quarterly, there were 3 pending results from the 6 patients who received the optimized treatment. 2 already had a cr, one did not. if 2 or all 3 have a cr, then things are looking really good imo. this news will be out in the next quarterly at the end of this ...more  
Comment by Kingpin68 on Jul 12, 2021 4:59pm
No sure what happened in that last post... from the previous quarterly, there were 3 pending results from the 6 patients who received the optimized treatment. 2 already had a cr, one did not. if 2 or all 3 have a cr, then things are looking really good imo. this news will be out in the next quarterly at the end of this month, plus, hopefully some other good news.
Comment by Sosak1 on Jul 12, 2021 8:34am
This is why insiders are buying and not selling. But it is shame that people have to loose bladder. I have seen it first hand. Seven hours operation. Very long recovery. And sleeping on your back only. All this what is happenig here is BS. Election is comming. Talk to your governmet.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250